Monoamine neurotransmitter transporter (MAT)

Cerebral monoamine neurotransmitter reuptake pathways are essential systems in the central nervous system responsible for regulating the duration and intensity of monoaminergic signaling (NIH, 2022). These pathways primarily involve three high-affinity transporters: the serotonin transporter (SERT/SLC6A4), the norepinephrine transporter (NET/SLC6A2), and the dopamine transporter (DAT/SLC6A3) (Wikipedia, 2024). These proteins, belonging to the solute carrier 6 (SLC6) family, utilize ion gradients to move neurotransmitters from the synaptic cleft back into the presynaptic neuron for recycling or degradation (MDPI, 2022). Dysregulation of these reuptake mechanisms is central to the pathophysiology of various neuropsychiatric conditions, such as major depressive disorder, anxiety, and ADHD (ResearchGate, 2021). Pharmacological modulation of these pathways is a cornerstone of modern psychiatry, with drugs like selective serotonin reuptake inhibitors (SSRIs) and stimulants being widely prescribed to restore neurotransmitter balance (StatPearls, 2023). Additionally, these transporters are the primary sites of action for several substances of abuse, including cocaine and amphetamines, which can lead to neurotoxicity and addiction (NIH, 2022).

Other names

Cerebral monoamine neurotransmitter reuptake pathwaysMonoamine transporterBiogenic amine transporterSLC6 family monoamine transportersMonoamine reuptake system

Inhibition of the reuptake of monoamine neurotransmitters (serotonin, norepinephrine, and dopamine) from the synaptic cleft into the presynaptic neuron, thereby increasing their extracellular concentration and prolonging their signaling (StatPearls, 2023; NIH, 2022).